Trends in Combination Antipsychotic Use Among Persons With Commercial Insurance: A Data Snapshot

| March 5, 2012 | 0 Comments

by Leslie Citrome, MD, MPH; Zhenchao Guo, PhD; Iftekhar Kalsekar, PhD; Robert A. Forbes, PhD; and Tony Hebden, PhD
Dr. Citrome is with the Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York; Drs. Kalsekar, Guo, and Hebden are with Bristol-Myers Squibb, Plainsboro, New Jersey Dr. Forbes is with Otsuka Pharmaceutical Development and Commercialization, Princeton, New Jersey.

Innov Clin Neurosci. 2012;9(3):17–18

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , ,

Category: Bipolar Disorder, Brief Report, Mood Disorders, Past Articles, Psychiatry, Psychopharmacology, Report, Schizophrenia

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.